Why the study?
Does 4-aminopyridine prevent rate-related depression of cardiac action potentials in animal cardiac tissue models?
Does 4-aminopyridine prevent rate-related depression of cardiac action potentials in animal cardiac tissue models?
4-aminopyridine prevents rate-related depression of cardiac action potentials, suggesting the mechanism involves time-dependent recovery of the early outward current, which may relate to deceleration-dependent bundle branch block.
Answers are grounded in this paper and cite their sources.
Animal data implicate early outward current in rate-related action potential changes; leaves open relevance to deceleration-dependent bundle branch block.
Canine cardiac Purkinje fibers and atrial trabeculae and rat and cat papillary muscles superfused with a hyperkalemic, hypoxic, and acidotic Tyrode solution were depolarized to membrane potentials (-70 to -60 mV) at which action potential amplitude declined as the coupling intervals of pacing stimuli were prolonged from 500 to 4,500 ms. The rate-related decline of action potential amplitude appeared to be due to time-dependent recovery of the early outward current rather than to a decrease in inward calcium current, since it was prevented by 4-aminopyridine (1.0 mM), but not by isoproterenol (1.0 microM), caffeine (5.0 mM), or CsCl (5-20 mM) and it was accompanied by an exponential increase of developed tension. Experiments using Purkinje fibers mounted in a single sucrose gap chamber demonstrated that the rate-related decline of action potential amplitude was maximal at membrane potentials between -70 and -40 mV and was negligible at less negative or more negative membrane potentials. These results may pertain to the mechanism for deceleration-dependent bundle branch block.
No takes yet. Share an insight, caveat, or question.
Gilmour et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: